After we confirmed that kidney and skin tissues from patients with SLE and lupus-prone mice express increased amounts of HA we considered that blockade of UGT should result in decreased HA expression and limited accumulation of immune cells to tissues. Here, SLC35A2 is linked to systemic lupus erythematosus.